Biden proposal on 'march-in' rights would have limited effect on current drug costs, critics say
As the Biden administration rolls out new draft guidance around the use of march-in rights on high-priced drugs, some critics argue that …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
